His primary areas of investigation include Breast cancer, Pathology, Molecular pathology, Cancer and Cancer research. His Breast cancer study deals with the bigger picture of Internal medicine. As part of the same scientific family, Jorge S. Reis-Filho usually focuses on Pathology, concentrating on Ductal carcinoma and intersecting with Hyperplasia.
His research in Molecular pathology intersects with topics in Gene expression profiling, Amplicon, Disease, Comparative genomic hybridization and Anatomical pathology. His work in Cancer addresses subjects such as Genetic heterogeneity, which are connected to disciplines such as Genetic diversity. His Cancer research study integrates concerns from other disciplines, such as Carcinogenesis, Chromogenic in situ hybridization, Targeted therapy and Epidermal growth factor receptor.
The scientist’s investigation covers issues in Breast cancer, Cancer research, Pathology, Cancer and Internal medicine. His Breast cancer research is multidisciplinary, incorporating perspectives in Molecular pathology, Gene and Bioinformatics. Jorge S. Reis-Filho works mostly in the field of Cancer research, limiting it down to concerns involving Mutation and, occasionally, Germline.
His Pathology study combines topics from a wide range of disciplines, such as Ductal carcinoma and Comparative genomic hybridization. His Cancer research includes themes of Genetic heterogeneity, Germline mutation and Basal. His study looks at the relationship between Internal medicine and fields such as Oncology, as well as how they intersect with chemical problems.
Jorge S. Reis-Filho focuses on Cancer research, Breast cancer, Cancer, Internal medicine and Oncology. His Cancer research research integrates issues from Exome sequencing, Somatic cell, Carcinogenesis, Mutation and Gene. The Breast cancer study which covers Genetic heterogeneity that intersects with CDKN2A.
His Cancer research includes elements of Transcriptome, Lung cancer and DNA sequencing. His Oncology course of study focuses on Precision medicine and Translational research. His Ductal carcinoma study frequently links to related topics such as Pathology.
Jorge S. Reis-Filho spends much of his time researching Cancer research, Breast cancer, Internal medicine, Oncology and Cancer. The various areas that Jorge S. Reis-Filho examines in his Cancer research study include Mutation, Transcription factor, Gene, Mutant and Estrogen receptor alpha. His research in Breast cancer is mostly concerned with Estrogen receptor.
His work on Lapatinib, Trastuzumab, Survival analysis and Serous ovarian cancer is typically connected to Clinical Practice as part of general Internal medicine study, connecting several disciplines of science. He interconnects Precision medicine, Clinical trial, Metastatic breast cancer and Intratumor heterogeneity in the investigation of issues within Oncology. His Cancer research is multidisciplinary, relying on both Fusion gene and MEDLINE.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Triple-negative breast cancer.
William D. Foulkes;Ian E. Smith;Jorge S. Reis-Filho.
The New England Journal of Medicine (2010)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo.
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado;R. Salgado;C. Denkert;S. Demaria;N. Sirtaine.
Annals of Oncology (2015)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn;Carla Milagre;Steven Whittaker;Arnaud Nourry.
Basal-Like Breast Cancer: A Critical Review
Emad A. Rakha;Jorge S. Reis-Filho;Ian O. Ellis.
Journal of Clinical Oncology (2008)
Triple negative tumours : a critical review
J S Reis-Filho;Andrew Tutt;Andrew Tutt.
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.
Fei Su;Amaya Viros;Carla Milagre;Kerstin Trunzer.
The New England Journal of Medicine (2012)
Complex landscapes of somatic rearrangement in human breast cancer genomes.
Philip J. Stephens;David J. Mcbride;Meng-lay Lin;Ignacio Varela.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: